Saturnus Bio, Inc.
PrivateLast Round
Seed
Jun 23, 2026
Total Funding Raised
$50M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Saturnus Bio, Inc. is a biotechnology company that develops precision medicines using targeted gene modulation to treat rare genetic cardiomyopathies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saturnus Bio, Inc. Comparables
Compare Saturnus Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tenaya Therapeutics | 74% | |
| BridgeBio Pharma, Inc. | 71% | |
| Rocket Pharmaceuticals, Inc. | 67% |
Saturnus Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 23, 2026 |
Saturnus Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Versant Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
$50M round led by Merck
Saturnus Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Saturnus Bio, Inc.'s valuation, stock price, and market status.
Is Saturnus Bio, Inc. a public or private company?
Saturnus Bio, Inc. is a private company.
What is the current stock price of Saturnus Bio, Inc.?
Saturnus Bio, Inc. is a private company with no public stock price. Caplight tracks Saturnus Bio, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Saturnus Bio, Inc. worth (valuation)?
Valuation information for Saturnus Bio, Inc. is not publicly available.
Can I buy Saturnus Bio, Inc. stock?
Saturnus Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Saturnus Bio, Inc.'s last funding round?
Saturnus Bio, Inc.'s most recent funding round was Seed on June 23, 2026.
Who are the main investors in Saturnus Bio, Inc.?
Key investors in Saturnus Bio, Inc. include Versant Ventures.
Will Saturnus Bio, Inc. IPO soon?
No public IPO plans have been announced for Saturnus Bio, Inc..
How can I track Saturnus Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Saturnus Bio, Inc.'s secondary market activity and sign up for updates.